+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
ID07268833

Using Single-Cell Analysis to Find New Biomarkers and Treatments for ALS Aiming for a Liquid Nerve Biopsy to Detect Early Disease Changes

Led by Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta · Updated on 2025-12-08

400

Participants Needed

4

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating amyotrophic lateral sclerosis ALS, a severe neurodegenerative disease characterized by motor neuron degeneration and no current cure. This study aims to discover new, reliable biomarkers and understand ALS mechanisms by analyzing changes in peripheral nerve tissue. The research focuses on early pathological events in ALS, including damage to motor axons and neuromuscular connections, using a novel PNS perspective to reveal cell-specific molecular alterations in nerve tissue during disease progression. The study involves analyzing human nerve biopsies from living ALS patients collected during diagnostic procedures, combined with data from preclinical mouse models. This approach will help identify protein biomarkers linked to early disease stages. The researchers will study various cell types within peripheral nerves, such as Schwann cells and macrophages, to understand their role in ALS pathology. Skin biopsies will be used to detect deregulated nerve signatures, and candidate molecular targets will be screened in biofluids from ALS patients and individuals at genetic risk. Participants include ALS patients, neuropathy patients, presymptomatic individuals, healthy controls, and patients with other neurodegenerative diseases. The study measures diagnostic biomarkers over 20 months and evaluates prognostic biomarkers and therapeutic targets over 24 months. Participants will undergo clinical assessments, biopsies, and biofluid sampling. This observational study is conducted under medical supervision to improve ALS diagnosis and treatment development by uncovering early disease markers and mechanisms.

CONDITIONS

Brief Title

Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here